psychological effects of glp 1 TheCut just released an article on one the long-term side of GLP-1s psychological effects of glp 1

Under current FDA guidance, a 503A pharmacy can compound a GLP-1 medication for a specific patient only when the prescriber documents a "significant difference" - a genuine clinical reason why the compounded formulation serves that patient's specific medical need in a way the commercially available FDA-approved product cannot

and prioritizing prospective studies to validate signal strength and refine risk mitigation strategies

For patients with pre-existing osteopenia or osteoporosis, a baseline DXA may change the risk-benefit calculation of GLP-1 therapy entirely

doi:10.1038/s41591-024-03374-z Borlaug BA, Zile MR, Kramer CM, et al

A recent review of saffron extract in people with diabetes found that the supplement did reduce A1C and fasting glucose, but had no significant effect on insulin levels